Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56,807 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
El Hussein S, Medeiros LJ, Lyapichev KA, Fang H, Jelloul FZ, Fiskus W, Chen J, Wei P, Schlette E, Xu J, Li S, Kanagal-Shamanna R, Yang H, Tang Z, Thakral B, Loghavi S, Jain N, Thompson PA, Ferrajoli A, Wierda WG, Jabbour E, Patel KP, Dabaja BS, Bhalla KN, Khoury JD. El Hussein S, et al. Among authors: yang h. Pathology. 2023 Jun;55(4):514-524. doi: 10.1016/j.pathol.2022.12.354. Epub 2023 Feb 25. Pathology. 2023. PMID: 36933995
Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant.
El Hussein S, Medeiros LJ, Gruschkus SK, Wei P, Schlette E, Fang H, Jelloul FZ, Wang W, Fiskus W, Kanagal-Shamanna R, Loghavi S, Yang H, Li S, Xu J, Tang Z, Thakral B, Jain N, Wierda WG, Patel K, Bhalla KN, Khoury JD. El Hussein S, et al. Among authors: yang h. Virchows Arch. 2023 Jun;482(6):1011-1019. doi: 10.1007/s00428-023-03520-x. Epub 2023 Mar 3. Virchows Arch. 2023. PMID: 36864257
Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
Khogeer H, Rahman H, Jain N, Angelova EA, Yang H, Quesada A, Ok CY, Sui D, Wei P, Al Fattani A, Pierce S, Loghavi S, Lamb A, Hu P, Thakral B, Kanagal-Shamanna R, Jorgensen JL, Jabbour EJ, Kantarjian HM, Medeiros LJ, Khoury JD. Khogeer H, et al. Among authors: yang h. Br J Haematol. 2019 Aug;186(4):538-548. doi: 10.1111/bjh.15960. Epub 2019 May 22. Br J Haematol. 2019. PMID: 31115909 Free article.
Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC.
Decker WK, Shah N, Xing D, Lapushin R, Li S, Robinson SN, Yang H, Parmar S, Halpert MM, Keating MJ, Gribben JG, Molldrem JJ, Shpall EJ, Wierda WG. Decker WK, et al. Among authors: yang h. PLoS One. 2012;7(12):e51390. doi: 10.1371/journal.pone.0051390. Epub 2012 Dec 19. PLoS One. 2012. PMID: 23284688 Free PMC article.
Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cells.
Steiner D, Gelovani J, Savoldo B, Robinson SN, Decker WK, Brouard N, Najjar A, Xing D, Yang H, Li S, Marini F, Zweidler-McKay PA, Bollard CM, Shpall EJ, Dotti G, Simmons PJ. Steiner D, et al. Among authors: yang h. Stem Cells. 2009 Aug;27(8):1932-40. doi: 10.1002/stem.111. Stem Cells. 2009. PMID: 19544439 Free PMC article.
FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells.
Liu X, Robinson SN, Setoyama T, Tung SS, D'Abundo L, Shah MY, Yang H, Yvon E, Shah N, Yang H, Konopleva M, Garcia-Manero G, McNiece I, Rezvani K, Calin GA, Shpall EJ, Parmar S. Liu X, et al. Among authors: yang h. Bone Marrow Transplant. 2014 Jun;49(6):793-9. doi: 10.1038/bmt.2014.57. Epub 2014 Apr 7. Bone Marrow Transplant. 2014. PMID: 24710569 Free PMC article.
Ex vivo expansion of umbilical cord blood.
Robinson S, Niu T, de Lima M, Ng J, Yang H, McMannis J, Karandish S, Sadeghi T, Fu P, del Angel M, O'Connor S, Champlin R, Shpall E. Robinson S, et al. Among authors: yang h. Cytotherapy. 2005;7(3):243-50. doi: 10.1080/14653240510027172. Cytotherapy. 2005. PMID: 16081350 Review.
Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease.
Parmar S, Liu X, Tung SS, Robinson SN, Rodriguez G, Cooper LJ, Yang H, Shah N, Yang H, Konopleva M, Molldrem JJ, Garcia-Manero G, Najjar A, Yvon E, McNiece I, Rezvani K, Savoldo B, Bollard CM, Shpall EJ. Parmar S, et al. Among authors: yang h. Cytotherapy. 2014 Jan;16(1):90-100. doi: 10.1016/j.jcyt.2013.07.009. Epub 2013 Oct 26. Cytotherapy. 2014. PMID: 24480547 Free PMC article.
56,807 results
You have reached the last available page of results. Please see the User Guide for more information.